Pharmacologic perspective on the physiology of the lower urinary tract.
about
Angiogenic factors, bladder neuroplasticity and interstitial cystitis-new pathobiological insightsChanges of neuregulin-1 (NRG-1) expression in a rat model of overactive bladder induced by partial urethral obstruction: is NRG-1 a new biomarker of overactive bladder?Inducible knockout mutagenesis reveals compensatory mechanisms elicited by constitutive BK channel deficiency in overactive murine bladder.Bladder dysfunction and altered somatic sensitivity in PACAP-/- mice.VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCGVEGF induces sensory and motor peripheral plasticity, alters bladder function, and promotes visceral sensitivity.Role of Purinergic Signaling in Voiding Dysfunction.Mechanisms of disease: involvement of the urothelium in bladder dysfunction.Current trends in the evaluation and management of female urinary incontinence.Animal models in urological disease and sexual dysfunction.The autonomous bladder: a view of the origin of bladder overactivity and sensory urge.Comparative pharmacological analysis of Rho-kinase inhibitors and identification of molecular components of Ca2+ sensitization in the rat lower urinary tract.Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.Mirabegron: a Beta-3 agonist for overactive bladder.Monitoring Detrusor Oxygenation and Hemodynamics Noninvasively during Dysfunctional Voiding.The emergence of new drugs for overactive bladder.The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.Purinergic signalling in the urinary tract in health and disease.Purinergic signalling in the lower urinary tract.The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors.Purinergic Signalling: Therapeutic Developments.Decreased phosphatase activity, increased Ca2+ sensitivity, and myosin light chain phosphorylation in urinary bladder smooth muscle of newborn mice.Effect of human chorionic gonadotrophin on in vitro contractions of stimulated detrusor muscle strips of female rats.Role of capsaicin-sensitive nerve fibers in uterine contractility in the rat.The role of the rhabdosphincter in female rat voiding.Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study.Comorbidities of bladder pain syndrome/interstitial cystitis: a population-based study.Development of contractile properties in the fetal porcine urinary bladder.Interstitial cells of Cajal in the murine gallbladder.Structural differences between the bladder dome and trigone revealed by mRNA expression analysis of cold-cut biopsies.
P2860
Q26773577-E5235032-AABF-4580-A98F-5946E80C4398Q33589756-4802B11E-2044-448D-A11A-CFB5FCBF1557Q33630889-246FF903-097A-45DF-8DAB-66E0861D1B7EQ34051297-E29643D8-B90A-4FAC-826B-E43255C811BAQ34068680-7231E614-7A43-444E-890F-64F06A3C2062Q34515175-632B2784-C424-47CD-884E-69466CD98DCEQ34973917-DA172504-6052-43D9-AC85-F3C854C16683Q35057494-9E2FCF21-A991-4C6F-B8B6-497437B1F90AQ35113508-6AE11210-9BF2-40FF-8D6D-A8FEB0BE6A99Q35545746-0809568A-D7A6-420D-BD1F-1B49943BBE3EQ35685704-2F68DCCB-8B52-4475-9A63-D8EE7B937ADFQ36004804-E6792928-FA02-4D3E-AAAD-7750723D8047Q36056143-B1F7473F-40CA-4B3A-99C9-3488D62A690FQ36160960-B3825CFB-63DA-460B-9639-64000A0D139AQ36277499-CA8B3BA6-EA95-4B58-9459-D8A5A3D4F313Q36407417-80EBFB19-6B91-490C-9A8A-848067840561Q36428471-78AC6CE4-22BC-4924-83BB-187EAA8CE4A2Q37620260-1F7A3BA8-68CD-49F1-A47E-2592D1C3919BQ38061933-6EC9A455-809D-4F83-9064-20DC4EE97416Q38062410-1785E1E3-A8E9-464A-88C1-6764234357CEQ42367885-31E8FEBA-0C48-49D8-8600-2B208ABF2648Q42554670-7893D288-3AC2-43DE-8EBF-0B4C4F978E55Q43165409-0072A851-EFB0-45B5-B9A7-2BAABDD90971Q44605088-A05AB35D-A108-4816-89C7-E62C1BCF654CQ44951592-FFB6A602-88A8-4776-8D80-CD4B6B68451AQ46176776-8D58BC68-B7C1-4820-AF04-DA6F4E1F2102Q48604072-4A75A679-7ECA-49AF-8529-DE777C664BA7Q49615706-3984EF30-3A28-4E21-B0C1-BACF803228DDQ50475611-F665ED13-AA7E-4E0F-A95B-3EBA46240DD3Q54392152-CB46E0D6-859D-49C9-A58D-CAFC5309878A
P2860
Pharmacologic perspective on the physiology of the lower urinary tract.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacologic perspective on the physiology of the lower urinary tract.
@ast
Pharmacologic perspective on the physiology of the lower urinary tract.
@en
type
label
Pharmacologic perspective on the physiology of the lower urinary tract.
@ast
Pharmacologic perspective on the physiology of the lower urinary tract.
@en
prefLabel
Pharmacologic perspective on the physiology of the lower urinary tract.
@ast
Pharmacologic perspective on the physiology of the lower urinary tract.
@en
P1433
P1476
Pharmacologic perspective on the physiology of the lower urinary tract.
@en
P2093
Karl-Erik Andersson
Petter Hedlund
P304
13-20; discussion 20-1
P356
10.1016/S0090-4295(02)01786-7
P407
P433
P577
2002-11-01T00:00:00Z